Walleye Trading LLC Reata Pharmaceuticals Inc Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$20.71 - $36.5 $108,748 - $191,661	5,251 New	5,251 $160,000
Q1 2022 May 16, 2022	SELL	$24.12 - $39.6 $167,995 - $275,814	-6,965 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$25.61 - $110.96 $174,327 - $755,304	6,807 Added 4308.23%	6,965 $184,000
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $426,613 - $851,234	-3,436 Reduced 95.6%	158 $23,000
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $253,258 - $340,295	3,554 Added 8885.0%	3,594 $289,000
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $44,378 - $53,873	-571 Reduced 93.45%	40 $4,000
Q1 2019 May 15, 2019	SELL	$51.9 - $101.79 $305,223 - $598,626	-5,881 Reduced 90.59%	611 $52,000
Q2 2018 Aug 14, 2018	BUY	$19.94 - $40.96 $129,450 - $265,912	6,492 New	6,492 $227,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.